Overexpression of Monocyte Chemotactic Protein-1/CCL2 in β-Amyloid Precursor Protein Transgenic Mice Show Accelerated Diffuse β-Amyloid Deposition

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · see citing works

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.

Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9649 · Cited by 1,525 · see citing works

A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity

Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388 · see citing works

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies

McGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367 · see citing works

Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo

Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E., Frosch, M., Eckman, C., Tanzi, R., Selkoe, D., & Guénette, S. (2003) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0230450100 · Cited by 1,361 · see citing works

Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease

Lim, G. P., Yang, F., Chu, T., Chen, P., Beech, W. K., Teter, B., Tran, T., Ubeda, O. J., Ashe, K. H., Frautschy, S. A., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-15-05709.2000 · Cited by 876 · see citing works

A Novel Geneiba1in the Major Histocompatibility Complex Class III Region Encoding an EF Hand Protein Expressed in a Monocytic Lineage

Imai, Y., Ibata, I., Ito, D., Ohsawa, K., & Kohsaka, S. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1112 · Cited by 872 · see citing works

Identification of the major Aβ1–42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition

Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., Kawashima-Morishima, M., Lee, H.-J., Hama, E., Sekine-Aizawa, Y., et al. (2000) · Nature Medicine · doi:10.1038/72237 · Cited by 867 · see citing works

Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails.

Charo, I. F., Myers, S. J., Herman, A., Franci, C., Connolly, A. J., & Coughlin, S. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2752 · Cited by 705 · see citing works

Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins

Pitas, R. E., Boyles, J. K., Lee, S. H., Foss, D., & Mahley, R. W. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90295-5 · Cited by 693 · see citing works

NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo

Eriksen, J. L., Sagi, S. A., Smith, T. E., Weggen, S., Das, P., McLendon, D. C., Ozols, V. V., Jessing, K. W., Zavitz, K. H., Koo, E. H., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18162 · Cited by 634 · see citing works

Amyloid precursor protein processing and Aβ 42 deposition in a transgenic mouse model of Alzheimer disease

Johnson‐Wood, K., Lee, M., Motter, R. N., Hu, K., Gordon, G., Barbour, R., Khan, K., Gordon, M. N., Tan, H. T., Games, D., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1550 · Cited by 634 · see citing works

Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E

Barger, S. W., & Harmon, A. D. (1997) · Nature · doi:10.1038/42257 · Cited by 622 · see citing works

Microglial response to amyloid plaques in APPsw transgenic mice.

Frautschy, S. A., Yang, F., Irrizarry, M., Hyman, B. T., Saido, T. C., Hsiao, K., & Cole, G. M. (1998) · Europe PMC (PubMed Central) · Cited by 592 · see citing works

TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice

Wyss-Coray, T., Lin, C., Yan, F., Yu, G.-Q., Rohde, M., McConlogue, L., Masliah, E., & Mucke, L. (2001) · Nature Medicine · doi:10.1038/87945 · Cited by 587 · see citing works

Interleukin-1 Expression in Different Plaque Types in Alzheimerʼs Disease

Griffin, W. S. T., Sheng, J. G., Roberts, G. W., & Mrak, R. E. (1995) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199503000-00014 · Cited by 546 · see citing works

Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins

Hsiao, K., Borchelt, D., Olson, K., Johannsdottir, R., Kitt, C. A., Yunis, W. S., Xu, S., Eckman, C., Younkin, S. G., Price, D., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90107-8 · Cited by 519 · see citing works

Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis

Ransohoff, R. M., Hamilton, T. A., Tani, M., Stoler, M. H., Shick, H. E., Major, J. A., Estes, M. L., Thomas, D. M., & Tuohy, V. K. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.6.8472896 · Cited by 496 · see citing works

Apolipoprotein E is essential for amyloid deposition in the <i>APP</i> ^V717F transgenic mouse model of Alzheimer's disease

Bales, K. R., Verina, T., Cummins, D. J., Du, Y., Dodel, R. C., Saura, J., Fishman, C. E., DeLong, C. A., Piccardo, P., Petegnief, V., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15233 · Cited by 486 · see citing works

An important role for the chemokine macrophage inflammatory protein-1 α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis

Karpus, W. J., Lukacs, N. W., McRae, B. L., Strieter, R. M., Kunkel, S. L., & Miller, S. D. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.10.5003 · Cited by 482 · see citing works

Anti-Inflammatory Drug Therapy Alters β-Amyloid Processing and Deposition in an Animal Model of Alzheimer's Disease

Yan, Q., Zhang, J., Liu, H., Babu-Khan, S., Vassar, R., Biere, A. L., Citron, M., & Landreth, G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-20-07504.2003 · Cited by 469 · see citing works

Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice

Wyss-Coray, T., Yan, F., Lin, A. H.-T., Lambris, J. D., Alexander, J. J., Quigg, R. J., & Masliah, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162350199 · Cited by 446 · see citing works

Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy

Bacskai, B. J., Kajdasz, S. T., Christie, R. H., Carter, C., Games, D., Seubert, P. A., Schenk, D., & Hyman, B. T. (2001) · Nature Medicine · doi:10.1038/85525 · Cited by 445 · see citing works

Glial cytokines in Alzheimer's disease: Review and pathogenic implications

Mrak, R. E., Sheng, J. G., & Griffin, W. S. T. (1995) · Human Pathology · doi:10.1016/0046-8177(95)90001-2 · Cited by 414 · see citing works

Brain Dendritic Cells and Macrophages/Microglia in Central Nervous System Inflammation

Fischer, H., & Reichmann, G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2717 · Cited by 408 · see citing works

Absence of C1q Leads to Less Neuropathology in Transgenic Mouse Models of Alzheimer's Disease

Fonseca, M. I., Zhou, J., Botto, M., & Tenner, A. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0901-04.2004 · Cited by 345 · see citing works

Microglial Activation and β-Amyloid Deposit Reduction Caused by a Nitric Oxide-Releasing Nonsteroidal Anti-Inflammatory Drug in Amyloid Precursor Protein Plus Presenilin-1 Transgenic Mice

Jantzen, P. T., Connor, K. E., DiCarlo, G., Wenk, G. L., Wallace, J. L., Rojiani, A. M., Coppola, D., Morgan, D., & Gordon, M. N. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02246.2002 · Cited by 337 · see citing works

Nonsteroidal Anti-Inflammatory Drugs Can Lower Amyloidogenic Aß ₄₂ by Inhibiting Rho

Zhou, Y., Su, Y., Li, B., Liu, F., Ryder, J. W., Wu, X., Gonzalez-DeWhitt, P. A., Gelfanova, V., Hale, J. E., May, P. C., et al. (2003) · Science · doi:10.1126/science.1090154 · Cited by 316 · see citing works

Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain

Glabinski, A. R., Balasingam, V., Tani, M., Kunkel, S. L., Strieter, R. M., Yong, V. W., & Ransohoff, R. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.11.4363 · Cited by 309 · see citing works

Evidence That Synaptically Released β-Amyloid Accumulates as Extracellular Deposits in the Hippocampus of Transgenic Mice

Lazarov, O., Lee, M., Peterson, D. A., & Sisodia, S. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09785.2002 · Cited by 302 · see citing works

Inflammatory factors are elevated in brain microvessels in Alzheimer's disease

Grammas, P. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00276-7 · Cited by 292 · see citing works

Nascent astrocyte particles differ from lipoproteins in CSF

LaDu, M. J., Gilligan, S. M., Lukens, J. R., Cabana, V. G., Reardon, C. A., Van Eldik, L. J., & Holtzman, D. M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70052070.x · Cited by 285 · cited 1× · see citing works

Reply to: 'Clearance of amyloid β-peptide from brain: transport or metabolism?'

Iwata, N., Tsubuki, S., Hama, E., Takaki, Y., Shirotani, K., & Saido, T. C. (2000) · Nature Medicine · doi:10.1038/77399 · Cited by 285 · see citing works

Mechanisms of Neuronal Death in Alzheimer's Disease

Cotman, C. W., & Su, J. H. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00878.x · Cited by 272 · see citing works

Slow Degradation of Aggregates of the Alzheimer's Disease Amyloid β-Protein by Microglial Cells

Paresce, D. M., Chung, H., & Maxfield, F. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.29390 · Cited by 269 · see citing works

Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease

Xia, M., & Hyman, B. T. (1999) · Journal of NeuroVirology · doi:10.3109/13550289909029743 · Cited by 269 · see citing works

Identification of monocyte chemoattractant protein‐1 in senile plaques and reactive microglia of Alzheimer's disease

ISHIZUKA, K., KIMURA, T., IGATA‐YI, R., KATSURAGI, S., TAKAMATSU, J., & MIYAKAWA, T. (1997) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1997.tb02375.x · Cited by 245 · see citing works

Intracranially Administered Anti-Αβ Antibodies Reduce β-Amyloid Deposition by Mechanisms Both Independent of and Associated with Microglial Activation

Wilcock, D. M., DiCarlo, G., Henderson, D., Jackson, J., Clarke, K., Ugen, K. E., Gordon, M. N., & Morgan, D. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-09-03745.2003 · Cited by 232 · see citing works

Transcriptional Regulation of BACE1, the β-Amyloid Precursor Protein β-Secretase, by Sp1

Christensen, M. A., Zhou, W., Qing, H., Lehman, A., Philipsen, S., & Song, W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.865-874.2004 · Cited by 218 · see citing works

Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice

Tan, J., Town, T., Crawford, F., Mori, T., DelleDonne, A., Crescentini, R., Obregon, D., Flavell, R. A., & Mullan, M. J. (2002) · Nature Neuroscience · doi:10.1038/nn968 · Cited by 217 · see citing works

Microglial activation facilitates Aβ plaque removal following intracranial anti-Aβ antibody administration

Wilcock, D. M., Munireddy, S. K., Rosenthal, A., Ugen, K. E., Gordon, M. N., & Morgan, D. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.09.015 · Cited by 202 · see citing works

Time-dependent reduction in Aβ levels after intracranial LPS administration in APP transgenic mice

Herber, D., Roth, L. M., Wilson, D., Wilson, N., Mason, J. E., Morgan, D., & Gordon, M. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.07.007 · Cited by 164 · see citing works

The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APPSW mice

Wegiel, J. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00181-0 · Cited by 159 · see citing works

A Synthetic Peptide Blocking the Apolipoprotein E/β-Amyloid Binding Mitigates β-Amyloid Toxicity and Fibril Formation in Vitro and Reduces β-Amyloid Plaques in Transgenic Mice

Sadowski, M., Pankiewicz, J., Scholtzova, H., Ripellino, J. A., Li, Y., Schmidt, S. D., Mathews, P. M., Fryer, J. D., Holtzman, D. M., Sigurdsson, E. M., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63355-x · Cited by 154 · see citing works

Chronic expression of monocyte chemoattractant protein‐1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice

Huang, D., Wujek, J. R., Kidd, G. J., He, T. T., Cardona, A. E., Sasse, M. E., Stein, E. J., Kish, J., Tani, M., Charo, I. F., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3104com · Cited by 140 · see citing works

The Interaction between Apolipoprotein E and Alzheimer's Amyloid β-Peptide Is Dependent on β-Peptide Conformation

Golabek, A. A., Soto, C. A., Vogel, T., & Wısnıewskı, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10602 · Cited by 137 · see citing works

Oxidized neprilysin in aging and Alzheimer’s disease brains

Wang, D.-S., Iwata, N., Hama, E., Saido, T. C., & Dickson, D. W. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.003 · Cited by 131 · see citing works

3D-Reconstruction of microglia and amyloid in APP23 transgenic mice: no evidence of intracellular amyloid

Stalder, M., Deller, T., Staufenbiel, M., & Jucker, M. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00209-3 · Cited by 118 · see citing works

Presenilin 1 Regulates Pharmacologically Distinct γ-Secretase Activities

Murphy, M. P., Uljon, S., Fraser, P. E., Fauq, A. H., Lookingbill, H. A., Findlay, K. A., Smith, T. E., Lewis, P. A., McLendon, D. C., Wang, R., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002812200 · Cited by 96 · see citing works

Production of Monocyte Chemotactic Protein‐1 By Rat Brain Macrophages

Calvo, C., Yoshirnura, T., Gelrnan, M., & Mallat, M. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01316.x · Cited by 94 · see citing works

Differential Degradation of Amyloid β Genetic Variants Associated with Hereditary Dementia or Stroke by Insulin-degrading Enzyme*

Morelli, L., Llovera, R., González, S., Affranchino, J. L., Prelli, F., Frangione, B., Ghiso, J., & Castaño, E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300276200 · Cited by 84 · see citing works

Microglial apolipoprotein E and astroglial apolipoprotein J expression in vitro: opposite effects of lipopolysaccharide

Saura, J., Petegnief, V., Wu, X., Liang, Y., & Paul, S. M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01788.x · Cited by 83 · see citing works

Pertussis Toxin-Induced Reversible Encephalopathy Dependent on Monocyte Chemoattractant Protein-1 Overexpression in Mice

Huang, D., Tani, M., Wang, J., Han, Y., He, T. T., Weaver, J., Charo, I. F., Tuohy, V. K., Rollins, B. J., & Ransohoff, R. M. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10633.2002 · Cited by 61 · see citing works

Alzheimer β Amyloid Deposition Enhanced by ApoE ɛ4 Gene precedes Neurofibrillary pathology in the Frontal Association Cortex of Nondemented Senior Subjects

Yamaguchi, H., Sugihara, S., Ogawa, A., Oshima, N., & Ihara, Y. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.7.731 · Cited by 56 · see citing works

C1q–calreticulin induced oxidative neurotoxicity: relevance for the neuropathogenesis of Alzheimer's disease

Luo, X., Weber, G. A., Zheng, J., Gendelman, H. E., & Ikezu, T. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00444-7 · Cited by 45 · see citing works

Amyloid precursor protein‐processing products affect mononuclear phagocyte activation: pathways for sAPP‐ and Aβ‐mediated neurotoxicity

Ikezu, T., Luo, X., Weber, G. A., Zhao, J., McCabe, L., Buescher, J. L., Ghorpade, A., Zheng, J., & Xiong, H. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01739.x · Cited by 39 · see citing works

l-Serine-mediated release of apolipoprotein E and lipids from microglial cells

Mori, K., Yokoyama, A., Yang, L., Yang, L., Maeda, N., Mitsuda, N., & Tanaka, J. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.10.010 · Cited by 23 · see citing works

OTK18 expression in brain mononuclear phagocytes parallels the severity of HIV-1 encephalitis

Carlson, K. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.01.021 · Cited by 22 · see citing works

Effects of Rofecoxib or Naproxen vs Placebo on Alzheimer Disease Progression: A Randomized Controlled Trial

Aisen, P. S., Schafer, K. A., Grundman, M., Pfeiffer, E., Sano, M., Davis, K. L., Farlow, M. R., Jin, S., Thomas, R. G., Thal, L. J., et al. (2003) · JAMA · doi:10.1001/jama.289.21.2819 · Cited by 5 · see citing works

Untitled work

Ard (1996) · doi:10.1002/(sici)1097-4547(19960115)43:2

Untitled work

Wyss-Coray (2006) · doi:10.1038/nm1484 · Cited by 1,284 · see citing works

Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions

Mildner, A., Schmidt, H., Nitsche, M., Merkler, D., Hanisch, U.-K., Mack, M., Heikenwalder, M., Brück, W., Priller, J., & Prinz, M. (2007) · Nature Neuroscience · doi:10.1038/nn2015 · Cited by 1,089 · see citing works

Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature

Wyss-Coray, T., & Rogers, J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006346 · Cited by 975 · see citing works

Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease

El Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., & Luster, A. D. (2007) · Nature Medicine · doi:10.1038/nm1555 · Cited by 915 · see citing works

Immune activation in brain aging and neurodegeneration: too much or too little?

Lucin, K. M., & Wyss-Coray, T. (2009) · Neuron · doi:10.1016/j.neuron.2009.08.039 · Cited by 679 · see citing works

CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models

Lee, S., Varvel, N. H., Konerth, M. E., Xu, G., Cardona, A. E., Ransohoff, R. M., & Lamb, B. T. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100265 · Cited by 539 · see citing works

Increased MCP-1 and microglia in various regions of the human alcoholic brain

He, J., & Crews, F. T. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.11.017 · Cited by 516 · see citing works

Inflammatory process in Alzheimer's Disease

Meraz-Ríos, M. A., Toral-Rios, D., Franco-Bocanegra, D., Villeda-Hernández, J., & Campos-Peña, V. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00059 · Cited by 427 · see citing works

Microglia and Inflammation in Alzheimers Disease

Mandrekar-Colucci, S., & Landreth, G. E. (2010) · CNS &amp; Neurological Disorders - Drug Targets · doi:10.2174/187152710791012071 · Cited by 421 · see citing works

The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases

Conductier, G., Blondeau, N., Guyon, A., Nahon, J., & Rovère, C. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.010 · Cited by 405 · see citing works

Interferon-γ and Tumor Necrosis Factor-α Regulate Amyloid-β Plaque Deposition and β-Secretase Expression in Swedish Mutant APP Transgenic Mice

Yamamoto, M., Kiyota, T., Horiba, M., Buescher, J. L., Walsh, S. M., Gendelman, H. E., & Ikezu, T. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060378 · Cited by 367 · see citing works

Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors

Zelcer, N., Khanlou, N., Clare, R., Jiang, Q., Reed-Geaghan, E. G., Landreth, G. E., Vinters, H. V., & Tontonoz, P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701096104 · Cited by 358 · see citing works

Distinct and Non-Redundant Roles of Microglia and Myeloid Subsets in Mouse Models of Alzheimer's Disease

Mildner, A., Schlevogt, B., Kierdorf, K., Böttcher, C., Erny, D., Kummer, M. P., Quinn, M., Brück, W., Bechmann, I., Heneka, M. T., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6209-10.2011 · Cited by 351 · see citing works

RAGE‐dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease

Fang, F., Lue, L.-F., Yan, S., Xu, H., Luddy, J. S., Chen, D., Walker, D. G., Stern, D. M., Yan, S., Schmidt, A. M., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-139634 · Cited by 335 · see citing works

Immunology and immunotherapy of Alzheimer's disease

Weiner, H. L., & Frenkel, D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1843 · Cited by 335 · see citing works

CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's Disease

Westin, K., Buchhave, P., Nielsen, H., Minthon, L., Janciauskiene, S., & Hansson, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030525 · Cited by 277 · see citing works

Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice

Janelsins, M. C., Mastrangelo, M. A., Oddo, S., LaFerla, F. M., Federoff, H. J., & Bowers, W. J. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-23 · Cited by 260 · see citing works

Monocyte Chemoattractant Protein‐1 Plays a Dominant Role in the Chronic Inflammation Observed in Alzheimer's Disease

Sokolova, A., Hill, M. D., Rahimi, F., Warden, L. A., Halliday, G. M., & Shepherd, C. E. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00188.x · Cited by 249 · see citing works

Current status of chemokines in the adult CNS

Goazigo, A. R.-L., Steenwinckel, J. V., Rostène, W. H., & Parsadaniantz, S. M. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.02.001 · Cited by 237 · see citing works

Chronic Neuron-Specific Tumor Necrosis Factor-Alpha Expression Enhances the Local Inflammatory Environment Ultimately Leading to Neuronal Death in 3xTg-AD Mice

Janelsins, M. C., Mastrangelo, M. A., Park, K. M., Sudol, K. L., Narrow, W. C., Oddo, S., LaFerla, F. M., Callahan, L. M., Federoff, H. J., & Bowers, W. J. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080528 · Cited by 220 · see citing works

Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases

Bose, S., & Cho, J. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0161-z · Cited by 221 · see citing works

The immunology of neurodegeneration

Czirr, E., & Wyss‐Coray, T. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58656 · Cited by 211 · see citing works

CNS expression of anti‐inflammatory cytokine interleukin‐4 attenuates Alzheimer's disease‐like pathogenesis in APP+PS1 bigenic mice

Kiyota, T., Okuyama, S., Swan, R. J., Jacobsen, M. T., Gendelman, H. E., & Ikezu, T. (2010) · The FASEB Journal · doi:10.1096/fj.10-155317 · Cited by 212 · see citing works

Impact of Cytokines and Chemokines on Alzheimer’s Disease Neuropathological Hallmarks

Domingues, C., Silva, O. A. B. D. C. E., & Henriques, A. G. (2017) · Current Alzheimer Research · doi:10.2174/1567205014666170317113606 · Cited by 212 · see citing works

Amyloid deposition and inflammation in APPswe/PS1dE9 mouse model of Alzheimer's disease.

Ruan, L., Kang, Z., Pei, G., & Le, Y. (2009) · Current Alzheimer Research · doi:10.2174/156720509790147070 · Cited by 181 · see citing works

Clearance of Amyloid-β Peptides By Microglia and Macrophages: the Issue of What, When and Where

Lai, A. Y., & McLaurin, J. (2012) · Future Neurology · doi:10.2217/fnl.12.6 · Cited by 161 · see citing works

CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer’s disease model

Krauthausen, M., Kummer, M. P., Zimmermann, J., Reyes-Irisarri, E., Terwel, D., Bulic, B., Heneka, M. T., & Müller, M. (2014) · Journal of Clinical Investigation · doi:10.1172/jci66771 · Cited by 147 · see citing works

FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders

Kiyota, T., Dixie, K. L. I., Jacobsen, M. T., Xiong, H., & Ikezu, T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102349108 · Cited by 145 · see citing works

Tau‐tubulin kinase 1 (TTBK1), a neuron‐specific tau kinase candidate, is involved in tau phosphorylation and aggregation

Sato, S., Cerny, R. L., Buescher, J. L., & Ikezu, T. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04059.x · Cited by 143 · see citing works

Current and emerging avenues for Alzheimer's disease drug targets

Loera‐Valencia, R., Cedazo-Mı́nguez, Á., Kenigsberg, P.-A., Page, G., Duarte, A. I., Giusti, P., Zusso, M., Robert, P. H., Frisoni, G. B., Cattaneo, A., et al. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12959 · Cited by 139 · see citing works

Chronic expression of monocyte chemoattractant protein‐1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice

Huang, D., Wujek, J. R., Kidd, G. J., He, T. T., Cardona, A. E., Sasse, M. E., Stein, E. J., Kish, J., Tani, M., Charo, I. F., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3104com · Cited by 140 · see citing works

Pyroglutamate-3 Amyloid-β Deposition in the Brains of Humans, Non-Human Primates, Canines, and Alzheimer Disease–Like Transgenic Mouse Models

Frost, J. L., Le, K. X., Cynis, H., Ekpo, E., Kleinschmidt, M., Palmour, R. M., Ervin, F. R., Snigdha, S., Cotman, C. W., Saido, T. C., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.05.005 · Cited by 132 · see citing works

Acute Hypoxia Induced an Imbalanced M1/M2 Activation of Microglia through NF-κB Signaling in Alzheimer’s Disease Mice and Wild-Type Littermates

Zhang, F., Zhong, R., Li, S., Fu, Z., Cheng, C., Cai, H., & Le, W. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00282 · Cited by 125 · see citing works

Opposing Effects of Membrane-Anchored CX3CL1 on Amyloid and Tau Pathologies via the p38 MAPK Pathway

Lee, S., Xu, G., Jay, T. R., Bhatta, S., Kim, K.-W., Jung, S., Landreth, G. E., Ransohoff, R. M., & Lamb, B. T. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0853-14.2014 · Cited by 123 · see citing works

A deficiency in CCR2+ monocytes: the hidden side of Alzheimer’s disease

Naert, G., & Rivest, S. (2013) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt028 · Cited by 123 · see citing works

Modulation of inflammation in transgenic models of Alzheimer’s disease

Birch, A. M., Katsouri, L., & Sastre, M. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-25 · Cited by 119 · see citing works

CCL2 Accelerates Microglia-Mediated Aβ Oligomer Formation and Progression of Neurocognitive Dysfunction

Kiyota, T., Yamamoto, M., Xiong, H., Lambert, M. P., Klein, W. L., Gendelman, H. E., Ransohoff, R. M., & Ikezu, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006197 · Cited by 114 · see citing works

The role and therapeutic potential of monocytic cells in Alzheimer's disease

Malm, T., Koistinaho, M., Muona, A., Magga, J. M., & Koıstınaho, J. (2010) · Glia · doi:10.1002/glia.20973 · Cited by 105 · see citing works

A highly insoluble state of Aβ similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice

Philipson, O., Hammarström, P., Nilsson, K. P. R., Portelius, E., Olofsson, T., Ingelsson, M., Hyman, B. T., Blennow, K., Lannfelt, L., Kalimo, H., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.022 · Cited by 106 · see citing works

CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy

Joly‐Amado, A., Hunter, J., Quadri, Z., Zamudio, F., Rocha-Rangel, P., Chan, D., Kesarwani, A., Nash, K. R., Lee, D. C., Morgan, D., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00997 · Cited by 104 · see citing works

Microglial activation in Alzheimer's disease.

Schlachetzki, J., & Hüll, M. H. (2009) · Current Alzheimer Research · doi:10.2174/156720509790147179 · Cited by 125 · see citing works

Role of Chemokines in the Development and Progression of Alzheimer’s Disease

Wojcieszak, J., Kuczyńska, K., & Zawilska, J. B. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02047-1 · Cited by 97 · see citing works

Animal models of amyloid‐β‐related pathologies in Alzheimer’s disease

Philipson, O., Lord, A., Gumucio, A., O'Callaghan, P. W., Lannfelt, L., & Nilsson, L. N. G. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07564.x · Cited by 98 · see citing works

Biomarker-based dissection of neurodegenerative diseases

Olsson, B., Zetterberg, H., Hampel, H. J., & Blennow, K. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.04.006 · Cited by 96 · see citing works

Inflammation in transgenic mouse models of neurodegenerative disorders

Schwab, C., Klegeris, A., & McGeer, P. L. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.10.013 · Cited by 97 · see citing works

Neural Stem Cell Transplants Improve Cognitive Function Without Altering Amyloid Pathology in an APP/PS1 Double Transgenic Model of Alzheimer’s Disease

Zhang, W., Wang, P., Sha, H., Ni, J., Li, M., & Gu, G.-J. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8640-x · Cited by 96 · see citing works

Diverse activation of microglia by chemokine (C-C motif) ligand 2 overexpression in brain

Selenica, M. B., Alvarez, J. A., Nash, K. R., Lee, D. C., Cao, C., Lin, X., Reid, P., Mouton, P. R., Morgan, D., & Gordon, M. N. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-86 · Cited by 96 · see citing works

Spatial Learning Impairment, Enhanced CDK5/p35 Activity, and Downregulation of NMDA Receptor Expression in Transgenic Mice Expressing Tau-Tubulin Kinase 1

Sato, S., Xu, J., Okuyama, S., Martinez, L. B., Walsh, S. M., Jacobsen, M. T., Swan, R. J., Schlautman, J. D., Ciborowski, P. S., & Ikezu, T. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3417-08.2008 · Cited by 93 · see citing works

CCL2 affects β-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer's disease

Kiyota, T., Gendelman, H. E., Weir, R. A., Higgins, E. E., Zhang, G., & Jain, M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.08.009 · Cited by 90 · see citing works

TNF-α-induced chemokine production and apoptosis in human neural precursor cells

Sheng, W. S., Hu, S., Ni, H. T., Rowen, T. N., Lokensgard, J. R., & Peterson, P. K. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0405221 · Cited by 86 · see citing works

Reduction of Amyloid Angiopathy and Aβ Plaque Burden after Enriched Housing in TgCRND8 Mice

Ambrée, O., Leimer, U., Herring, A., Goertz, N., Sachser, N., Heneka, M. T., Paulus, W., & Keyvani, K. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051107 · Cited by 85 · see citing works

Neurons burdened by DNA double-strand breaks incite microglia activation through antiviral-like signaling in neurodegeneration

Welch, G. M., Boix, C. A., Schmauch, E., Davila-Velderrain, J., Victor, M. B., Dileep, V., Bozzelli, P. L., Su, Q., Cheng, J. D., Lee, A., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo4662 · Cited by 84 · see citing works

LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases

Xu, P., Li, D.-B., Tang, X., Bao, X., Huang, J., Tang, Y.-P., Yang, Y., Xu, H., & Fan, X.-T. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8461-3 · Cited by 84 · see citing works

Peripheral Chemo-Cytokine Profiles in Alzheimers and Parkinsons Diseases

Reale, M., Greig, N., & Kamal, M. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709789055199 · Cited by 82 · see citing works

Oxidative Stress, Aging, and Central Nervous System Disease in the Canine Model of Human Brain Aging

Head, E., Rofina, J., & Zicker, S. C. (2008) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2007.10.002 · Cited by 78 · see citing works

Chlamydia pneumoniae: An Etiologic Agent for Late-Onset Dementia

Balin, B. J., Hammond, C. J., Little, C. S., Hingley, S. T., Al-Atrache, Z., Appelt, D. M., Whittum-Hudson, J. A., & Hudson, A. P. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00302 · Cited by 77 · see citing works

Amyloid β and Tau Alzheimer’s disease related pathology is reduced by Toll-like receptor 9 stimulation

Scholtzova, H., Chianchiano, P. E., Pan, J., Sun, Y., Goñi, F., Mehta, P. D., & Wısnıewskı, T. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0101-2 · Cited by 77 · see citing works

Neuroimmune contributions to Alzheimer’s disease: a focus on human data

Haage, V., & De Jager, P. L. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01637-0 · Cited by 74 · see citing works

Plaque-Associated Overexpression of Insulin-Degrading Enzyme in the Cerebral Cortex of Aged Transgenic Tg2576 Mice With Alzheimer Pathology

Leal, M. C., Dorfman, V. B., Fernández-Gamba, A. C., Frangione, B., Wısnıewskı, T., Castaño, E. M., Sigurdsson, E. M., & Morelli, L. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000235853.70092.ba · Cited by 74 · see citing works

The role of the immune system in driving neuroinflammation

Ní Chasaide, C., & Lynch, M. A. (2020) · Brain and Neuroscience Advances · doi:10.1177/2398212819901082 · Cited by 72 · see citing works

Tau-tubulin kinase

Ikezu, S., & Ikezu, T. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00033 · Cited by 67 · see citing works

Platelet-derived growth factor (PDGF)-BB-mediated induction of monocyte chemoattractant protein 1 in human astrocytes: implications for HIV-associated neuroinflammation

Bethel-Brown, C. S., Yao, H., Hu, G., & Buch, S. J. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-262 · Cited by 69 · see citing works

AAV1/2-mediated CNS Gene Delivery of Dominant-negative CCL2 Mutant Suppresses Gliosis, β-amyloidosis, and Learning Impairment of APP/PS1 Mice

Kiyota, T., Yamamoto, M., Schroder, B., Jacobsen, M. T., Swan, R. J., Lambert, M. P., Klein, W. L., Gendelman, H. E., Ransohoff, R. M., & Ikezu, T. (2009) · Molecular Therapy · doi:10.1038/mt.2009.44 · Cited by 68 · see citing works

Effects of long-term moderate ethanol and cholesterol on cognition, cholinergic neurons, inflammation, and vascular impairment in rats

Ehrlich, D., Pirchl, M., & Humpel, C. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.12.054 · Cited by 65 · see citing works

TGF-β1 blockade of microglial chemotaxis toward Aβ aggregates involves SMAD signaling and down-regulation of CCL5

Huang, W.-C., Yen, F.-C., Shie, F., Pan, C., Shiao, Y.-J., Yang, C.-N., Huang, F.-L., Sung, Y. J., & Tsay, H. J. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-28 · Cited by 64 · see citing works

Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer’s disease

Hartlage‐Rübsamen, M., Waniek, A., Meißner, J., Morawski, M., Schilling, S., Jäger, C., Kleinschmidt, M., Cynis, H., Kehlen, A., Arendt, T., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1395-2 · Cited by 61 · see citing works

Elevated Expression of MiR-17 in Microglia of Alzheimer’s Disease Patients Abrogates Autophagy-Mediated Amyloid-β Degradation

Estfanous, S. Z. K., Daily, K. P., Eltobgy, M. M., Deems, N. P., Anne, M. N. K., Krause, K., Badr, A., Hamilton, K., Carafice, C., Hegazi, A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.705581 · Cited by 63 · see citing works

Liver X receptors: Emerging therapeutic targets for Alzheimer's disease

Sodhi, R. K., & Singh, N. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.03.008 · Cited by 61 · see citing works

Role of the Macrophage Inflammatory Protein-1α/CC Chemokine Receptor 5 Signaling Pathway in the Neuroinflammatory Response and Cognitive Deficits Induced by β-Amyloid Peptide

Passos, G. F., Figueiredo, C. P., Prediger, R. D., Pandolfo, P., Duarte, F. S., Medeiros, R., & Calixto, J. Β. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081113 · Cited by 60 · see citing works

Immune cells may fend off Alzheimer disease

Britschgi, M., & Wyss‐Coray, T. (2007) · Nature Medicine · doi:10.1038/nm0407-408 · Cited by 60 · see citing works

Meningeal and choroid plexus cells—Novel drug targets for CNS disorders

Dragunow, M. (2013) · Brain Research · doi:10.1016/j.brainres.2013.01.013 · Cited by 50 · see citing works

The Roles of Monocyte and Monocyte‐Derived Macrophages in Common Brain Disorders

Zhao, M., Tuo, H., Wang, S., & Zhao, L. (2020) · BioMed Research International · doi:10.1155/2020/9396021 · Cited by 46 · see citing works

Chlamydia pneumoniae infection of monocytes in vitro stimulates innate and adaptive immune responses relevant to those in Alzheimer’s disease

Lim, C., Hammond, C. J., Hingley, S. T., & Balin, B. J. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0217-0 · Cited by 45 · see citing works

Tau‐tubulin kinase 1 enhances prefibrillar tau aggregation and motor neuron degeneration in P301L FTDP‐17 tau‐mutant mice

Xu, J., Sato, S., Okuyama, S., Swan, R. J., Jacobsen, M. T., Strunk, E., & Ikezu, T. (2010) · The FASEB Journal · doi:10.1096/fj.09-150144 · Cited by 41 · see citing works

Potential Immunotargets for Alzheimer's Disease Treatment Strategies

Fernández, P. L., Britton, G. B., & Rao, K. S. J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121222 · Cited by 37 · see citing works

Blood–brain barrier dysfunction promotes astrocyte senescence through albumin‐induced TGFβ signaling activation

Preininger, M. K., Zaytseva, D., Lin, J. M., & Kaufer, D. (2023) · Aging Cell · doi:10.1111/acel.13747 · Cited by 36 · see citing works

Ethanol Regulates Angiogenic Cytokines During Neural Development: Evidence From an in Vitro Model of Mitogen‐Withdrawal–Induced Cerebral Cortical Neuroepithelial Differentiation

Camarillo, C., Kumar, L. S., Bake, S., Sohrabji, F., & Miranda, R. C. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00308.x · Cited by 36 · see citing works

Reboxetine Treatment Reduces Neuroinflammation and Neurodegeneration in the 5xFAD Mouse Model of Alzheimer’s Disease: Role of CCL2

Gutiérrez, I. L., González‐Prieto, M., Caso, J. R., García‐Bueno, B., Leza, J. C., & Madrigal, J. L. M. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01695-6 · Cited by 35 · see citing works

Inflammatory pathway analytes predicting rapid cognitive decline in MCI stage of Alzheimer’s disease

Pillai, J. A., Bena, J., Bebek, G., Bekris, L. M., Bonner‐Jackson, A., Kou, L., Pai, A., Sørensen, L., Neilsen, M., Rao, S. M., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51109 · Cited by 34 · see citing works

Extensive temporal transcriptome and microRNA analyses identify molecular mechanisms underlying mitochondrial dysfunction induced by multi-walled carbon nanotubes in human lung cells

Nymark, P. E. H., Wijshoff, P., Cavill, R., van Herwijnen, M. H. M., Coonen, M. L. J., Claessen, S. M. H., Catalán, J., Norppa, H., Kleinjans, J. C. S., & Briedé, J. J. (2015) · Nanotoxicology · doi:10.3109/17435390.2015.1017022 · Cited by 32 · see citing works

CCR5 deficiency accelerates lipopolysaccharide-induced astrogliosis, amyloid-beta deposit and impaired memory function

Hwang, C. J., Park, M. H., Hwang, J. Y., Kim, J. H., Yun, N. Y., Oh, S. Y., Song, J. K., Seo, H. O., Kim, Y.-B., Hwang, D. Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7453 · Cited by 31 · see citing works

Bidirectional communication between brain and visceral white adipose tissue: Its potential impact on Alzheimer's disease

Huang, X., Wang, Y., & Xiang, Y. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104263 · Cited by 31 · see citing works

MCP-1 Signaling Disrupts Social Behavior by Modulating Brain Volumetric Changes and Microglia Morphology

Maldonado‐Ruiz, R., Trujillo-Villarreal, L. A., Montalvo-Martínez, L., Mercado-Gómez, O. F., Arriaga-Ávila, V. S., Garza‐Ocañas, L., Ortı́z-López, R., Garza‐Villarreal, E. A., Guevara‐Guzmán, R., & Camacho‐Morales, A. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02649-7 · Cited by 30 · see citing works

Cerebrospinal Fluid C-C Motif Chemokine Ligand 2 Correlates with Brain Atrophy and Cognitive Impairment in Alzheimer’s Disease

Kimura, A., Yoshikura, N., Hayashi, Y., & Inuzuka, T. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170519 · Cited by 29 · see citing works

Immunity to self and self-maintenance: what can tumor immunology teach us about ALS and Alzheimer's disease?

SCHWARTZ, M., & Ziv, Y. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.03.006 · Cited by 26 · see citing works

Longitudinal chemokine profile expression in a blood-brain barrier model from Alzheimer transgenic versus wild-type mice

Vérité, J., Janet, T., Chassaing, D., Fauconneau, B., Rabeony, H., & Page, G. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1220-7 · Cited by 25 · see citing works

Glutaminyl cyclases, the potential targets of cancer and neurodegenerative diseases

Zhang, Y., Wang, Y., Zhao, Z., Peng, W., Wang, P., Xu, X., & Zhao, C. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175178 · Cited by 25 · see citing works

Interleukin-31: A New Cytokine Involved in Inflammation of the Skin

Castellani, M. L., Salini, V., Frydas, S., Donelan, J., Madhappan, B., Petrarca, C., Vecchiet, J., Falasca, K., Neri, G., & Tetè, S. (2006) · International Journal of Immunopathology and Pharmacology · doi:10.1177/205873920601900101 · Cited by 25 · see citing works

Plasma MCP-1 and changes on cognitive function in community-dwelling older adults

Sánchez‐Sánchez, J. L., Giudici, K. V., Guyonnet, S., Delrieu, J., Li, Y., Bateman, R. J., Parini, A., Vellas, B. J., Barreto, P. D. S., for the MAPT/DSA Group, et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00940-2 · Cited by 24 · see citing works

Astrocyte- and Endothelial-Targeted CCL2 Conditional Knockout Mice: Critical Tools for Studying the Pathogenesis of Neuroinflammation

Ge, S., Murugesan, N., & Pachter, J. S. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9197-4 · Cited by 23 · see citing works

Monocyte chemoattractant protein-1 promoter polymorphism and plasma levels in alzheimer’s disease

Porcellini, E., Ianni, M., Carbone, I., Franceschi, M., & Licastro, F. (2013) · Immunity & Ageing · doi:10.1186/1742-4933-10-6 · Cited by 22 · see citing works

P2X7R influences tau aggregate burden in human tauopathies and shows distinct signalling in microglia and astrocytes

Beltran-Lobo, P., Hughes, M. M., Troakes, C., Croft, C. L., Rupawala, H., Jutzi, D., Ruepp, M., Jimenez-Sanchez, M., Perkinton, M., Kassiou, M., et al. (2023) · Brain, behavior, and immunity · doi:10.1016/j.bbi.2023.09.011 · Cited by 20 · see citing works

The Chemokine (C-C Motif) Ligand 2 in Neuroinflammation and Neurodegeneration

Madrigal, J. L. M., & Caso, J. R. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-07320-0_15 · Cited by 21 · see citing works

Association of cholinergic basal forebrain volume and functional connectivity with markers of inflammatory response in the Alzheimer’s disease spectrum

Teipel, S. J., Dyrba, M., Ballarini, T., Brosseron, F., Bruno, D., Buerger, K., Cosma, N.-C., Dechent, P., Dobisch, L., Düzel, E., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215196 · Cited by 20 · see citing works

Varoglutamstat: Inhibiting Glutaminyl Cyclase as a Novel Target of Therapy in Early Alzheimer’s Disease

Feldman, H., for the ADCS VIVA-MIND Study Group, Messer, K. S., Qiu, Y., Sabbagh, M., Galasko, D., Turner, R. S., López, O. L., Smith, A., Durant, J., et al. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231126 · Cited by 20 · see citing works

Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease

Bettinetti‐Luque, M., Trujillo‐Estrada, L., García‐Fuentes, E., Andreo‐Lopez, J., Sanchez-Varo, R. M., Garrido‐Sánchez, L., Mediavilla, A. G., López, M. G., García‐Caballero, M., Gutiérrez, A., et al. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16243 · Cited by 21 · see citing works

Cerebrospinal Fluid Chemokine (C-C Motif) Ligand 2 Is an Early-Response Biomarker for Blast-Overpressure-Wave–Induced Neurotrauma in Rats

Wang, Y., Wei, Y., Oguntayo, S., Wilder, D. M., Tong, L. C., Su, Y., Gist, I. D., Arun, P., & Long, J. B. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2016.4465 · Cited by 20 · see citing works

Epigenetic regulation of CC-chemokine ligand 2 in nonresolving inflammation

Kiguchi, N., Saika, F., Kobayashi, Y., & Kishioka, S. (2014) · BioMolecular Concepts · doi:10.1515/bmc-2014-0022 · Cited by 18 · see citing works

From Amyloid to Synaptic Dysfunction: Biomarker-Driven Insights into Alzheimer’s Disease

Agnello, L., Gambino, C. M., Ciaccio, A. M., Cacciabaudo, F., Massa, D., Masucci, A., Tamburello, M., Vassallo, R., Midiri, M., Scazzone, C., et al. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47080580 · Cited by 17 · see citing works

Chemokines in neurodegenerative diseases

Vida, H., Sahar, M., Nikdouz, A., & Hosseini, A. (2024) · Immunology and Cell Biology · doi:10.1111/imcb.12843 · Cited by 17 · see citing works

CCL2 Accelerates Microglia-Mediated Aβ Oligomer Formation and Progression of Neurocognitive Dysfunction

Kiyota, T., Yamamoto, M., Xiong, H., Lambert, M. P., Klein, W. L., Gendelman, H. E., Ransohoff, R. M., & Ikezu, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006197 · Cited by 114 · see citing works

CCL2 Accelerates Microglia-Mediated Ab Oligomer Formation and Progression of Neurocognitive

Kiyota, T., Yamamoto, M., 熊焕贵, Lambert, M. P., Klein William, L., Gendelman, H. E., Ransohoff, R. M., & Ikezu, T. (2009)

Association of Microglia with Amyloid Plaques in Brains of APP23 Transgenic Mice

Stalder, M., Phinney, A., Probst, A., Sommer, B., Staufenbiel, M., & Jucker, M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65423-5 · Cited by 345 · see citing works

CC Chemokine Receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease

Naert, G., & Rivest, S. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0299-11.2011 · Cited by 207 · see citing works

Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease

El Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., & Luster, A. D. (2007) · Nature Medicine · doi:10.1038/nm1555 · Cited by 915 · see citing works